By contrast, Vioxx made $2.5 billion for Merck last year.
Celebrex and Vioxx have become household names in recent years.
"He did so voluntarily," the agency said.
With Vioxx, researchers had been warning about the drug's possible cardiovascular risks since 2000, only a year after it was approved by the FDA.
The company was already facing two class action lawsuits alleging patient harm from Vioxx.
In his view, the new Vioxx data quantified the risk and made it manageable.
``This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx,'' Gilmartin began.
The FDA's own study of the Vioxx safety issue has become mired in controversy.
